Maureen Sampson
Overview
Explore the profile of Maureen Sampson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
903
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wolska A, Sampson M, Zubiran R, Meeusen J, Donato L, Jaffe A, et al.
Front Cardiovasc Med
. 2024 Nov;
11:1452869.
PMID: 39526185
Background: The triglyceride (TG) content of low-density lipoprotein (LDL-TG) has been shown to be more predictive of atherosclerotic cardiovascular disease (ASCVD) events than the cholesterol content of LDL (LDL-C). The...
2.
Lam R, Manemann S, Seehusen K, Remaley A, St Sauver J, Jiang R, et al.
Lipids Health Dis
. 2024 Jul;
23(1):210.
PMID: 38965543
Background: Low-density lipoprotein cholesterol (LDL-C) is associated with atherosclerotic cardiovascular disease (ASCVD). Friedewald, Sampson, and Martin-Hopkins equations are used to calculate LDL-C. This study compares the impact of switching between...
3.
Seehusen K, Remaley A, Sampson M, Meeusen J, Larson N, Decker P, et al.
J Am Heart Assoc
. 2024 Apr;
13(8):e031878.
PMID: 38591325
Background: Clinical risk scores are used to identify those at high risk of atherosclerotic cardiovascular disease (ASCVD). Despite preventative efforts, residual risk remains for many individuals. Very low-density lipoprotein cholesterol...
4.
Turecamo S, Downie C, Wolska A, Mora S, Otvos J, Connelly M, et al.
Am J Med
. 2024 Apr;
137(7):640-648.
PMID: 38583752
Background: Higher total serum cholesterol is associated with lower mortality in heart failure. Evaluating associations between lipoprotein subfractions and mortality among people with heart failure may provide insights into this...
5.
Kumar S, Conners K, Shearer J, Joo J, Turecamo S, Sampson M, et al.
J Am Heart Assoc
. 2024 Mar;
13(8):e031616.
PMID: 38533960
Background: Frailty is common in heart failure (HF) and is associated with death but not routinely captured clinically. Frailty is linked with inflammation and malnutrition, which can be assessed by...
6.
Joo J, Shearer J, Wolska A, Remaley A, Otvos J, Connelly M, et al.
Circ Genom Precis Med
. 2024 Mar;
17(2):e004312.
PMID: 38516784
Background: Heart failure is heterogeneous syndrome with persistently high mortality. Nuclear magnetic resonance spectroscopy enables high-throughput metabolomics, suitable for precision phenotyping. We aimed to use targeted metabolomics to derive a...
7.
Coverdell T, Sampson M, Zubiran R, Wolska A, Donato L, Meeusen J, et al.
Lipids Health Dis
. 2024 Feb;
23(1):43.
PMID: 38331834
Background: The accurate measurement of Low-density lipoprotein cholesterol (LDL-C) is critical in the decision to utilize the new lipid-lowering therapies like PCSK9-inhibitors (PCSK9i) for high-risk cardiovascular disease patients that do...
8.
Oyetoro R, Conners K, Joo J, Turecamo S, Sampson M, Wolska A, et al.
Front Cardiovasc Med
. 2024 Feb;
11:1293901.
PMID: 38327494
Background: The relationship between ketone bodies (KB) and mortality in patients with heart failure (HF) syndrome has not been well established. Objectives: The aim of this study is to assess...
9.
Sampson M, Wolska A, Zubiran R, Cole J, Amar M, Remaley A
Expert Rev Mol Diagn
. 2024 Jan;
24(1-2):123-133.
PMID: 38252511
Background: Lipid testing for atherosclerotic cardiovascular disease (ASCVD) risk is often performed every 4-6 years, but we hypothesized that the optimum time interval may vary depending on baseline risk. Research...
10.
Sampson M, Wolska A, Meeusen J, Otvos J, Remaley A
Clin Chem
. 2023 Nov;
70(2):399-402.
PMID: 38006320
No abstract available.